Karyopharm Therapeutics
KPTI
#9086
Rank
A$0.12 B
Marketcap
$1.02
Share price
-2.25%
Change (1 day)
-15.75%
Change (1 year)

Earnings for Karyopharm Therapeutics (KPTI)

Earnings in 2024 (TTM): -A$81.15 Million

According to Karyopharm Therapeutics 's latest financial reports the company's current earnings are A$0.14 Billion. In 2023 the company made an earning of -A$0.2 Billion, an increase over its 2022 earnings that were of -A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Karyopharm Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$81.15 Million-57.36%
2023 -A$0.2 Billion-14.99%
2022 -A$0.23 Billion43.11%
2021 -A$0.16 Billion-42.09%
2020 -A$0.28 Billion-8.07%
2019 -A$0.3 Billion5.76%
2018 -A$0.28 Billion33.02%
2017 -A$0.21 Billion19.28%
2016 -A$0.18 Billion-7.4%
2015 -A$0.19 Billion55.96%
2014 -A$0.13 Billion123.21%
2013 -A$54.31 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$23.95 B-27,444.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$11.01 Billion 12,464.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.84 B-12,478.33%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.95 B-1,195.58%๐Ÿ‡บ๐Ÿ‡ธ USA